vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and Vestis Corp (VSTS). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $663.4M, roughly 1.0× Vestis Corp). Natera, Inc. runs the higher net margin — 7.1% vs -1.0%, a 8.1% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs -3.0%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $28.3M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs -3.0%).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

Vestis Corp is a leading provider of workplace uniforms, safety apparel, and facility service solutions. It primarily operates across North America, serving clients in healthcare, manufacturing, retail, hospitality, and public service sectors, offering customized uniform rental, cleaning, and maintenance programs tailored to varied business operational requirements.

NTRA vs VSTS — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.0× larger
NTRA
$665.5M
$663.4M
VSTS
Growing faster (revenue YoY)
NTRA
NTRA
+42.8% gap
NTRA
39.8%
-3.0%
VSTS
Higher net margin
NTRA
NTRA
8.1% more per $
NTRA
7.1%
-1.0%
VSTS
More free cash flow
NTRA
NTRA
$9.5M more FCF
NTRA
$37.8M
$28.3M
VSTS
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
-3.0%
VSTS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NTRA
NTRA
VSTS
VSTS
Revenue
$665.5M
$663.4M
Net Profit
$47.3M
$-6.4M
Gross Margin
Operating Margin
-3.4%
2.5%
Net Margin
7.1%
-1.0%
Revenue YoY
39.8%
-3.0%
Net Profit YoY
187.9%
-868.1%
EPS (diluted)
$0.36
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
VSTS
VSTS
Q1 26
$663.4M
Q4 25
$665.5M
$712.0M
Q3 25
$592.2M
Q2 25
$546.6M
$673.8M
Q1 25
$501.8M
$665.2M
Q4 24
$476.1M
$683.8M
Q3 24
$439.8M
$684.3M
Q2 24
$413.4M
$698.2M
Net Profit
NTRA
NTRA
VSTS
VSTS
Q1 26
$-6.4M
Q4 25
$47.3M
$-12.5M
Q3 25
$-87.5M
Q2 25
$-100.9M
$-676.0K
Q1 25
$-66.9M
$-27.8M
Q4 24
$-53.8M
$832.0K
Q3 24
$-31.6M
$-2.3M
Q2 24
$-37.5M
$5.0M
Operating Margin
NTRA
NTRA
VSTS
VSTS
Q1 26
2.5%
Q4 25
-3.4%
2.5%
Q3 25
-16.5%
Q2 25
-20.2%
3.7%
Q1 25
-15.8%
-1.3%
Q4 24
-13.6%
4.4%
Q3 24
-8.9%
4.4%
Q2 24
-10.6%
5.4%
Net Margin
NTRA
NTRA
VSTS
VSTS
Q1 26
-1.0%
Q4 25
7.1%
-1.8%
Q3 25
-14.8%
Q2 25
-18.5%
-0.1%
Q1 25
-13.3%
-4.2%
Q4 24
-11.3%
0.1%
Q3 24
-7.2%
-0.3%
Q2 24
-9.1%
0.7%
EPS (diluted)
NTRA
NTRA
VSTS
VSTS
Q1 26
$-0.05
Q4 25
$0.36
$-0.10
Q3 25
$-0.64
Q2 25
$-0.74
$-0.01
Q1 25
$-0.50
$-0.21
Q4 24
$-0.41
$0.01
Q3 24
$-0.26
$-0.02
Q2 24
$-0.30
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
VSTS
VSTS
Cash + ST InvestmentsLiquidity on hand
$41.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
$864.4M
Total Assets
$2.4B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
VSTS
VSTS
Q1 26
$41.5M
Q4 25
$29.7M
Q3 25
$1.0M
Q2 25
$16.0M
$23.7M
Q1 25
$17.8M
$28.8M
Q4 24
$22.7M
$18.6M
Q3 24
$29.5M
$31.0M
Q2 24
$90.3M
$29.1M
Total Debt
NTRA
NTRA
VSTS
VSTS
Q1 26
Q4 25
$1.2B
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$1.2B
Q2 24
Stockholders' Equity
NTRA
NTRA
VSTS
VSTS
Q1 26
$864.4M
Q4 25
$1.7B
$865.6M
Q3 25
$1.3B
Q2 25
$1.2B
$882.2M
Q1 25
$1.2B
$876.3M
Q4 24
$1.2B
$899.6M
Q3 24
$878.5M
$903.1M
Q2 24
$836.5M
$901.2M
Total Assets
NTRA
NTRA
VSTS
VSTS
Q1 26
$2.9B
Q4 25
$2.4B
$2.9B
Q3 25
$1.8B
Q2 25
$1.8B
$2.9B
Q1 25
$1.7B
$2.9B
Q4 24
$1.7B
$2.9B
Q3 24
$1.6B
$2.9B
Q2 24
$1.5B
$3.1B
Debt / Equity
NTRA
NTRA
VSTS
VSTS
Q1 26
Q4 25
1.35×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.29×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
VSTS
VSTS
Operating Cash FlowLast quarter
$73.9M
$37.7M
Free Cash FlowOCF − Capex
$37.8M
$28.3M
FCF MarginFCF / Revenue
5.7%
4.3%
Capex IntensityCapex / Revenue
5.4%
1.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M
$45.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
VSTS
VSTS
Q1 26
$37.7M
Q4 25
$73.9M
$30.9M
Q3 25
$59.4M
Q2 25
$37.6M
$22.9M
Q1 25
$44.5M
$6.7M
Q4 24
$52.9M
$3.8M
Q3 24
$51.8M
$295.6M
Q2 24
$4.0M
$48.7M
Free Cash Flow
NTRA
NTRA
VSTS
VSTS
Q1 26
$28.3M
Q4 25
$37.8M
$15.6M
Q3 25
$37.0M
Q2 25
$11.7M
$8.0M
Q1 25
$22.6M
$-6.9M
Q4 24
$34.8M
$-11.0M
Q3 24
$35.5M
$267.5M
Q2 24
$-7.7M
$27.7M
FCF Margin
NTRA
NTRA
VSTS
VSTS
Q1 26
4.3%
Q4 25
5.7%
2.2%
Q3 25
6.2%
Q2 25
2.1%
1.2%
Q1 25
4.5%
-1.0%
Q4 24
7.3%
-1.6%
Q3 24
8.1%
39.1%
Q2 24
-1.9%
4.0%
Capex Intensity
NTRA
NTRA
VSTS
VSTS
Q1 26
1.4%
Q4 25
5.4%
2.2%
Q3 25
3.8%
Q2 25
4.7%
2.2%
Q1 25
4.3%
2.0%
Q4 24
3.8%
2.2%
Q3 24
3.7%
4.1%
Q2 24
2.8%
3.0%
Cash Conversion
NTRA
NTRA
VSTS
VSTS
Q1 26
Q4 25
1.56×
Q3 25
Q2 25
Q1 25
Q4 24
4.54×
Q3 24
Q2 24
9.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NTRA
NTRA

Segment breakdown not available.

VSTS
VSTS

Workplace Supplies$375.2M57%
Uniforms$227.7M34%
Other$60.5M9%

Related Comparisons